This Viewpoint discusses why the quick rise in popularity of cannabidiol (CBD) necessitates policy changes that promote clinical trials to establish the next wave of CBD as a safe, efficacious regulated approved for use medicine.
This randomized clinical trial compares the effects of family-focused therapy vs the standard therapy of enhanced care for symptomatic high-risk youths who have a family history of bipolar disorder.
This nationwide Swedish cohort study examines the risks of subjection to violence and perpetration of violence among patients with psychiatric disorders compared with siblings and individuals from the general population without psychiatric disorders.
This Viewpoint argues that overdose reversals via naloxone administration should be considered saved lives.
This randomized clinical trial examines the efficacy and safety of lumateperone for the short-term treatment of adults with schizophrenia.
This genome-wide association study examines the extent of overlap between the genetic architectures of major psychiatric disorders and body mass index and identifies common genetic loci.
This secondary analysis of a randomized clinical trial examines whether electroencephalographic connectivity could reveal neural moderators of antidepressant treatment.
Create a personal account or sign in to: